Franklin Resources’s Inhibrx INBX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.32M Buy
15,178
+1,835
+14% +$183K ﹤0.01% 2202
2026
Q2
$1.26M Sell
13,343
-20,864
-61% -$2.09M ﹤0.01% 2181
2026
Q1
$2.3M Buy
34,207
+4,899
+17% +$363K ﹤0.01% 1870
2025
Q4
$2.32M Buy
29,308
+12,144
+71% +$827K ﹤0.01% 1719
2025
Q3
$578K Sell
17,164
-5,006
-23% -$123K ﹤0.01% 2362
2025
Q2
$316K Buy
+22,170
New +$287K ﹤0.01% 2542
2024
Q3
– Sell
-22,577
Closed -$320K – 2972
2024
Q2
$320K Buy
+22,577
New +$353K ﹤0.01% 2413

Other funds holding INBX

Franklin Resources's INBX Position: Q3 2026 in Review

Franklin Resources increased its Inhibrx (INBX) stake by 14% in Q3 2026, buying an estimated $183K and bringing the position to 15,178 shares worth $1.32M. The position accounts for ﹤0.01% of the portfolio, ranked #2202.

Franklin Resources first reported a position in INBX in Q2 2024 and has held it in 7 quarters since. The position peaked at $2.32M in Q4 2025. 88 funds tracked by Wall St. Rank hold INBX as of Q3 2026.

  • Franklin Resources held 15,178 shares of Inhibrx worth $1.32M as of Q3 2026.
  • Franklin Resources bought 1,835 Inhibrx shares in Q3 2026, an estimated $183K.
  • Inhibrx made up ﹤0.01% of Franklin Resources's portfolio in Q3 2026, its #2202 holding.
  • Franklin Resources first reported a position in Inhibrx in Q2 2024 and has held it in 7 quarters since.
  • Franklin Resources's Inhibrx position peaked at $2.32M in Q4 2025.
  • 88 funds tracked by Wall St. Rank held Inhibrx as of Q3 2026.

Based on Franklin Resources's 13F filing for Q3 2026, filed 12 Nov 2026.